M0224 Insurance Policy Changes

HCPCS M0224 is officially defined as "Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring." No tracked policy changes reference HCPCS M0224 yet. New payer updates are added daily, so check back soon or create a free alert to be notified the moment a change affects this code.